Exclusives Archives - Page 63 of 102

2 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet Including 3 AI Names

April 13, 5:01 PM

Investors are on the hunt for undervalued, underfollowed and emerging stocks and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

AMST

3 minute read

EXCLUSIVE: 56% Of US Consumers May Cut Streaming Plans. Will They Keep Netflix, Disney+ Or Amazon Prime?

By Chris Katje

April 13, 12:02 PM

High inflation and job cuts have consumers concerned about spending and saving during the current economic times. One area that could see lower spending from consumers is streaming platforms.

AAPL

4 minute read

EXCLUSIVE: Geologist Stu Averill Describes Tower Resources’ Latest Discoveries As ‘Immediately Successful,’ Provides Details

By Melanie Schaffer

April 13, 10:27 AM

Renowned geologist and director of Tower Resources, Ltd (OTC: TWRFF), Stu Averill, spoke to Benzinga on Tuesday to discuss Tower’s results from its latest drilling program, which led to two additional discovery zones on its Rabbit North property in Kamloops, B.C.

NGD

2 minute read

EXCLUSIVE: Tesla Gains Favor Among US Consumers With High Trust In Products, But Would They Buy The Stock?

By Chris Katje

April 13, 8:30 AM

Electric vehicle leader Tesla Inc (NASDAQ: TSLA) is one of the most followed and talked about automotive and technology companies in the world.

TSLA

1 minute read

EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics’ Influenza Antibody

By Vandana Singh

April 13, 8:00 AM

The FDA has granted Fast Track designation for SAB Biotherapeutics' (NASDAQ: SABS) SAB-176, an investigational therapeutic for Type A and Type B influenza illness in high-risk patients, including those who have anti-viral resistant strains.

RHHBF

1 minute read

EXCLUSIVE: Ocean Biomedical’s Co-Founder Expects To Receive US Patent Covering Malaria Therapeutics

By Vandana Singh

April 13, 7:30 AM

Ocean Biomedical Inc's (NASDAQ: OCEA) co-founder, Jonathan Kurtis, has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for his U.S.

OCEA

1 minute read

EXCLUSIVE: Tiziana Life Sciences Plans To Develop Multiple Sclerosis Hopeful For Long COVID Patients

By Vandana Singh

April 13, 6:30 AM

Tiziana Life Sciences Ltd (NASDAQ: TLSA) plans to investigate intranasal foralumab for Long COVID. What Happened: The work is supported by foralumab's well-established role in de-activating microglia cells, a key component in this disease's pathogenesis.

TLSA

3 minute read

EXCLUSIVE: Can MSOs, Conditional Applicants Co-Exist In New York’s Rec Cannabis Market?

By Jelena Martinovic

April 12, 3:44 PM

New York is a classic case of the road to hell being paved with good intentions, Neil Kaufman, managing member of Kaufman McGowan PLLC, a Long Island corporate and securities law firm, said as he kicked off a discussion on the Empire State's cannabis market at

CCHWF

4 minute read

EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In Q1 2023 – Tesla, Apple, AMC, DWAC And More

By Chris Katje

April 12, 3:33 PM

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

$APE

2 minute read

EXCLUSIVE: Strategies From 4 Cannabis Industry Leaders To Combat Price Compression, Alternative Cannabinoids

By AJ Fabino

April 12, 1:37 PM

On day two of Benzinga's Cannabis Capital Conference in Miami, industry experts gathered to discuss the pressing issue of price compression in the cannabis sector.

SNDL